Navigation Links
CHEO scientist advances biotherapeutics as published in Cancer Cell
Date:10/18/2011

Ottawa, Ontario October 18, 2011 Oncolytic virology uses live viruses to sense the genetic difference between a tumor and normal cell. Once the virus finds a tumor cell, it replicates inside that cell, kills it and then spreads to adjacent tumor cells to seed a therapeutic "chain reaction". As reported in today's issue of Cancer Cell, Dr. David Stojdl, a scientist from the Children's Hospital of Eastern Ontario Research Institute at the University of Ottawa has found a way to trick resistant cancer cells into committing suicide following oncolytic virus therapy.

When it comes to using oncolytic viruses to fight cancer, the outcome is a consequence of a battle between the genes that the virus has and the genes that the human host has. Using a technology called RNA Interference (RNAi) Dr. Stojdl's research team was able to systematically search through the entire human genome to find genes [that when inhibited] would make the viruses up to 10,000 times more potent at killing tumor cells without harming healthy cells. "Until now, scientists in our field have been focused on engineering the genes in the oncolytic virus itself to make them work better, and that has worked well to a point. This is the first study to look at all of the genes in the human genome to determine which ones we should manipulate to help the oncolytic therapy work better," said Dr. Stojdl.

Dr. Stojdl's research team has identified a series of genes that magnify the impact of oncolytic viruses. These genes normally control the endoplasmic reticulum stress response, or unfolded protein response. In essence, when the cell environment is toxic the cells have a tough time folding proteins. "A properly folded protein doesn't expose many sticky parts on its surface. Cells don't like mangled proteins because they get sticky. If you have sticky parts they combine with other proteins to make large, toxic 'balls' of protein - and this can kill the cell," explained Dr. Stoj
'/>"/>

Contact: Adrienne Vienneau
avienneau@cheo.on.ca
613-737-7600 x4144
Children's Hospital of Eastern Ontario Research Institute
Source:Eurekalert

Page: 1 2

Related biology news :

1. Scientists first to characterize barley plant-stem rust spore communication
2. Scientists discover dietary moisture window that boosts urinary tract health in cats
3. Southampton scientists herald significant breakthrough in study of chlamydia
4. Scientists move closer to predicting who will and will not fight off severe infections
5. Tagging tumors with gold: Scientists use gold nanorods to flag brain tumors
6. Uncharted territory: Scientists sequence the first carbohydrate biopolymer
7. New drug target for Alzheimers, stroke is discovered by University at Buffalo scientists
8. Scientists discover 3 new gene faults which could increase melanoma risk by 30 percent
9. Scientists identify microbes responsible for consuming natural gas in Deepwater Horizon spill
10. University of Texas marine scientists awarded $5.6 million for study of critical Arctic environment
11. WUSTL scientist wins prestigious Presidential Early Career Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... Calif. , July 9, 2015  Synaptics Inc. (NASDAQ: ... solutions, announced today that it will report financial results ... Thursday, July 30, 2015 after the close of market. ... analysts and investors at 2:00 p.m. PT (5:00 p.m. ... To participate on the live call, analysts ...
(Date:7/8/2015)... NEW YORK , July 8, 2015 ... cancer globally, and the fourth most fatal, with a ... year. The poor prognosis of pancreatic cancer patients has ... to treatment, which is not being met by the ... contains an array of products with varying molecule types ...
(Date:7/7/2015)... 2015 Research and ... of the "Capacitive Fingerprint Sensors Patent Landscape" ... this date, fingerprint sensing technology is the most ... are well developed. This patent landscape focuses on ... The domain of capacitive fingerprint sensors is closely ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
... than a holiday favorite, given their remarkable nutritional and health ... international journal Advances in Nutrition provides ... and not just a side dish. The review authors conclude ... the incidence of certain infections, improve heart health and temper ...
... Diseases affecting the kidneys represent a major and unsolved ... they are damaged by disease, highlighting the urgent need ... Now, a team of researchers led by scientists ... a novel platform to study kidney diseases, opening new ...
... Acta Obstetricia et Gynecologica Scandinavica , a journal of ... indicate that human error is the most common cause ... of clinical skills, and failure to obtain senior medical ... claims following birth asphyxia. In Norway there ...
Cached Biology News:Cranberries have health-promoting properties, new expert review reveals 2Cranberries have health-promoting properties, new expert review reveals 3Salk scientists for the first time generate 'mini-kidney' structures from human stem cells 2Salk scientists for the first time generate 'mini-kidney' structures from human stem cells 3Human error most common cause of birth asphyxia 2
(Date:7/29/2015)... 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) ... Chief Financial Officer has resigned.  The Company has hired ... who retired in December 2014, as full time interim ... successor.     Andy Ashworth began his ... a smooth transition.  Andy was the Company,s CFO from ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... and supplier, announces the launch of their 2nd generation cell therapy POD® design. ... miniPOD CT, but it also represents a new POD® design. , “G-CON ...
(Date:7/29/2015)...  AmnioChor Inc., an early stage biotech startup based ... announce that the Musculoskeletal Transplant Foundation of ... their seed round of development of the proprietary AmnioCept™ ... AmnioChor,s technology allows cryopreservation of the amniotic ... living within those tissues. Amnion is a well-established source ...
(Date:7/29/2015)... , July 29, 2015  Indivior PLC (LON: INDV) ... naloxone nasal spray was accepted and received Priority Review ... the treatment of opioid overdose. This naloxone nasal spray ... formulated for optimal absorption into the nasal mucosa. 1 ... training so individuals may be better equipped to help ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5
... , WARSAW, Ind., Oct. 28 Zimmer Holdings, Inc. ... OMeGA Medical Grants Association LLC (OMeGA) has chosen its ... third party administrator for graduate medical education to which ... for the 2009-2010 academic year. , OMeGA received more ...
... PLYMOUTH MEETING, PA., Oct. 28 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Corporation ... today announced,the appointment of Daniel P. Harrington to the ... Mr. Harrington brings more than thirty years of management ... traded,companies. Since 1995, he has been President and CEO ...
... Oct. 28 GenVec, Inc. (Nasdaq: GNVC ) announced ... ended September 30, 2009 on Thursday, November 5, 2009 after ... a.m. EST on Friday, November 6, 2009 to discuss the ... ) , To listen to the live conference ...
Cached Biology Technology:Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 2Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 3Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 4BMP Sunstone Appoints Daniel Harrington to Board of Directors 2GenVec Announces Third Quarter 2009 Results Conference Call 2
... intended for use as a wash buffer for ... Fluid is useful for transportation of specimens (such ... studies. Samples may remain in Transport Fluid ... Michels Transport Fluid is not a fixative ...
... Systems provide rapid, precise localization of ... frozen or paraffin-embedded tissue, cytospins and ... facilitate double or triple labeleing experiments, ... with primary antibodies of different animal ...
... covers can be used with ... covers for stacking of covered ... for use with automated systems ... and non-ridged, are available for ...
SYBR Green Nucleic Acid Dye...
Biology Products: